GALENA BIOPHARMA INC's ticker is GALE and the CUSIP is 363256504. A total of 40 filers reported holding GALENA BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,702,228 | $953,000 | 0.06% |
| Crescent Grove Advisors, LLC | 120,000 | $42,000 | 0.01% |
| DAFNA Capital Management LLC | 46,145 | $16,000 | 0.01% |
| Winfield Associates, Inc. | 3,000 | $1,000 | 0.00% |
| Renaissance Technologies | 2,769,786 | $977,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 34,954 | $12,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 14,646 | $5,000 | 0.00% |
| NEXT Financial Group, Inc | 25 | $0 | 0.00% |
| IFP Advisors, Inc | 512 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 3 | $1,000 | 0.00% |